Research Topics
| Diego NovickSummaryAffiliation: Eli Lilly and Company Country: USA Publications
| Collaborators
|
Detail Information
Publications
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO studyDiego Novick
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK
Psychopharmacology (Berl) 191:1015-22. 2007..Symptomatic remission is an achievable goal of treatment in patients with schizophrenia...
Regional differences in treatment response and three year course of schizophrenia across the worldDiego Novick
European Health Outcomes Research, Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey GU20 6PH, UK
J Psychiatr Res 46:856-64. 2012..These results seem to indicate that patients from Latin America, East Asia, North Africa & Middle East may have a more favorable disease course than patients from European nations...- Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medicationsDiego Novick
Eli Lilly and Company, Windlesham, UK
Int Clin Psychopharmacol 27:275-82. 2012..In the usual care of outpatients with schizophrenia, treatment continuation among nonadherent patients is longer for depot typicals compared with oral typicals and is accompanied by less hospitalization in the short term... - Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes StudyDiego Novick
Health Outcomes Research, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
J Nerv Ment Dis 200:637-43. 2012..Olanzapine was found to have the highest monotherapy rate and the longest duration of maintained monotherapy, followed by risperidone, amisulpride, and quetiapine... - Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyDiego Novick
Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU206PH, UK
Eur Neuropsychopharmacol 19:542-50. 2009..In conclusion, antipsychotics have different tolerability profiles in terms of the adverse events we monitored. Results should be interpreted conservatively due to the observational study design... - Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophreniaDiego Novick
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK
Psychiatry Res 176:109-13. 2010..Also, reversal of some risk factors may improve adherence. Non-adherence is associated with a range of poorer long-term outcomes, with clinical and economic implications... - Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM studyD Novick
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, UK
Pharmacopsychiatry 42:145-52. 2009..The aim of this study was to compare the outcomes of olanzapine- and valproate-treated patients in an observational study of acute mania with the results of a randomised controlled trial (RCT) assessing the same treatments... - Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practiceDiego Novick
Lilly Research Centre, Windlesham, Surrey, UK
Int Clin Psychopharmacol 25:257-63. 2010..Limitations include differences in study design, patient population, and length of follow-up... - Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) studyDiego Novick
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK
Schizophr Res 108:223-30. 2009.... - Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes studyDiego Novick
Eli Lilly and Company, Windlesham, Surrey, UK
Int Clin Psychopharmacol 23:203-8. 2008..Patients who switched to olanzapine experienced a higher weight gain. In conclusion, among patients switching antipsychotic medication, those who switched to olanzapine had better long-term outcomes... - Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes studyDiego Novick
Lilly Research Centre, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
J Clin Psychopharmacol 30:531-40. 2010..Higher baseline clinical severity was associated with EPS development, whereas age, presence of EPS, a higher negative Clinical Global Impression score, and presence of gynecomastia were associated with TD development... - Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) studyDiego Novick
Eli Lilly and Company, Windlesham, Surrey, UK
Prog Neuropsychopharmacol Biol Psychiatry 29:972-82. 2005..The results should be interpreted conservatively due to the observational design of SOHO... - The number needed to treat for all-cause medication discontinuation in the treatment of schizophrenia: consistency across world geographies and study designsD Novick
European Outcomes Research, Eli Lilly and Co, Surrey, UK
Pharmacopsychiatry 43:81-5. 2010.... - Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) studyJihyung Hong
Personal Social Services Research Unit, London School of Economics, London, UK
Psychiatry Res 190:110-4. 2011..05). In conclusion, non-adherence in bipolar patients was associated with poorer long term clinical outcomes that have economic implications for health-care providers... - Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?Catherine Reed
Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, UK
Prog Neuropsychopharmacol Biol Psychiatry 33:715-21. 2009..4%) and week 12 (50.5%). The results of this observational study show that treatment for mania is complex with multiple combinations of treatment and frequent switching during an acute episode... - The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in SpainAntonio Ciudad
Clinical Research, Department of Research and Development, Lilly, S A Avda de la Industria, 30, 28108 Alcobendas, Madrid, Spain
Eur Psychiatry 23:1-7. 2008..This article presents the long-term results in terms of antipsychotic medication maintenance and factors influencing it in a representative sample of patients with schizophrenia recruited in the SOHO study within Spain... 
Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research DatabaseCatherine Reed
Global Health Outcomes, Eli Lilly and Company, Windlesham, Surrey, UK
Clinicoecon Outcomes Res 5:37-47. 2013..To assess the impact of pain severity and time to diagnosis of depression on health care costs for primary care patients with pre-existing unexplained pain symptoms who subsequently received a diagnosis of depression...- Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research DatabaseJihyung Hong
Personal Social Services Research Unit, London School of Economics and Political Science, London, United Kingdom
Spine (Phila Pa 1976) 38:75-82. 2013..Retrospective cohort study of health care costs associated with the treatment of chronic low back pain (CLBP) in the United Kingdom... - Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studiesDavid Suarez
Research and Development Unit, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, RETICS RD06 0011 REM TAP Network, Sant Boi, Barcelona, Spain
J Clin Epidemiol 61:525-30. 2008..Until now, MSMs have not been used to compare the effects of more than two treatments... - Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO studyMartin Knapp
Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK
Pharmacoeconomics 26:341-58. 2008..To determine the cost utility of treating schizophrenic patients with olanzapine compared with other antipsychotics in a naturalistic outpatient setting... - Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies resultsJosep Maria Haro
San Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Eur Neuropsychopharmacol 17:235-44. 2007..Antipsychotic maintenance in SOHO was higher than the results of previous randomized studies... - Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes studyJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
J Clin Psychopharmacol 26:571-8. 2006..The results should be interpreted conservatively because of the observational, nonrandomized study design... - Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophreniaJosep Maria Haro
Research and Development Unit, Sant Joan de Déu Serveis de Salut Mental, Dr Antoni Pujades 42, 08030 Sant Boi, Barcelona, Spain
Eur Psychiatry 21:41-7. 2006..The findings from this study should be interpreted conservatively because of its non-randomized observational design... - Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyIsabelle Gasquet
INSERM U669, Maison des Adolescents, Hopital Cochin, AP HP, Paris, France
Int Clin Psychopharmacol 20:199-205. 2005..The results should be interpreted conservatively due to the observational study design...